{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T17:40:24Z","timestamp":1765993224343,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T00:00:00Z","timestamp":1547510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Data"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fever in neutropenia (FN) is the most frequent potentially life threatening complication of chemotherapy for cancer. Prediction of the risk to develop complications, integrated into clinical decision rules, would allow for risk-stratified treatment of FN. This retrospective, single center cohort study in pediatric patients diagnosed with cancer before 17 years, covered two decades, 1993 to 2012. In total, 703 FN episodes in 291 patients with chemotherapy (maximum per patient, 9) were reported here. Twenty-nine characteristics of FN were collected: 6 were patient- and cancer-related, 8 were characteristics of history, 8 of clinical examination, and 7 laboratory results in peripheral blood, all known at FN diagnosis. In total 28 FN outcomes were assessed: 8 described treatment of FN, 6 described microbiologically defined infections (MDI), 4 clinically defined infections, 4 were additional clinical composite outcomes, and 6 outcomes were related to discharge. These data can mainly be used to study FN characteristics and their association with outcomes over time and between centers, and for derivation and external validation of clinical decision rules.<\/jats:p>","DOI":"10.1038\/sdata.2018.304","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T14:07:30Z","timestamp":1547561250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Episodes of fever in neutropenia in pediatric patients with cancer in Bern, Switzerland, 1993\u20132012"],"prefix":"10.1038","volume":"6","author":[{"given":"Maxime G.","family":"Zermatten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9965-5183","authenticated-orcid":false,"given":"Christa","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annina","family":"von Allmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Agyeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland A.","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"BFsdata2018304_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","volume":"64","author":"GP Bodey","year":"1966","unstructured":"Bodey, G. P., Buckley, M., Sathe, Y. S. & Freireich, E. J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64, 328\u2013340 (1966).","journal-title":"Ann Intern Med"},{"key":"BFsdata2018304_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/QCO.0b013e328351d199","volume":"25","author":"RA Ammann","year":"2012","unstructured":"Ammann, R. A., Tissing, W. J. & Phillips, B. Rationalizing the approach to children with fever in neutropenia. Curr Opin Infect Dis 25, 258\u2013265, https:\/\/doi.org\/10.1097\/QCO.0b013e328351d199 (2012).","journal-title":"Curr Opin Infect Dis"},{"key":"BFsdata2018304_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00043426-200201000-00011","volume":"24","author":"SW Alexander","year":"2002","unstructured":"Alexander, S. W., Wade, K. C., Hibberd, P. L. & Parsons, S. K. Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 24, 38\u201342 (2002).","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFsdata2018304_CR4","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s00520-004-0660-z","volume":"12","author":"RA Ammann","year":"2004","unstructured":"Ammann, R. A., Aebi, C., Hirt, A. & Ridolfi Luthy, A. Fever in neutropenia in children and adolescents: evolution over time of main characteristics in a single center, 1993\u20132001. Support Care Cancer 12, 826\u2013832, https:\/\/doi.org\/10.1007\/s00520-004-0660-z (2004).","journal-title":"Support Care Cancer"},{"key":"BFsdata2018304_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/mpo.10073","volume":"39","author":"E Orudjev","year":"2002","unstructured":"Orudjev, E. & Lange, B. J. Evolving concepts of management of febrile neutropenia in children with cancer. Med Pediatr Oncol 39, 77\u201385, https:\/\/doi.org\/10.1002\/mpo.10073 (2002).","journal-title":"Med Pediatr Oncol"},{"key":"BFsdata2018304_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2046-4053-1-8","volume":"1","author":"RS Phillips","year":"2012","unstructured":"Phillips, R. S. et al. Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol). Syst Rev 1, 8, https:\/\/doi.org\/10.1186\/2046-4053-1-8 (2012).","journal-title":"Syst Rev"},{"key":"BFsdata2018304_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/pbc.21041","volume":"49","author":"C Duncan","year":"2007","unstructured":"Duncan, C. et al. A prospective study of admissions for febrile neutropenia in secondary paediatric units in South East England. Pediatr Blood Cancer 49, 678\u2013681, https:\/\/doi.org\/10.1002\/pbc.21041 (2007).","journal-title":"Pediatr Blood Cancer"},{"key":"BFsdata2018304_CR8","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1200\/JCO.2009.25.8988","volume":"28","author":"RA Ammann","year":"2010","unstructured":"Ammann, R. A. et al. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol 28, 2008\u20132014, https:\/\/doi.org\/10.1200\/JCO.2009.25.8988 (2010).","journal-title":"J Clin Oncol"},{"key":"BFsdata2018304_CR9","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1542\/peds.2010-0734","volume":"127","author":"O Teuffel","year":"2011","unstructured":"Teuffel, O., Amir, E., Alibhai, S. M., Beyene, J. & Sung, L. Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer. Pediatrics 127, e279\u2013e286, https:\/\/doi.org\/10.1542\/peds.2010-0734 (2011).","journal-title":"Pediatrics"},{"key":"BFsdata2018304_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/pbc.24076","volume":"59","author":"E Brack","year":"2012","unstructured":"Brack, E. et al. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN Study. Pediatr Blood Cancer 59, 423\u2013430 (2012).","journal-title":"Pediatr Blood Cancer"},{"key":"BFsdata2018304_CR11","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","volume":"18","author":"J Klastersky","year":"2000","unstructured":"Klastersky, J. et al. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18, 3038\u20133051, https:\/\/doi.org\/10.1200\/JCO.2000.18.16.3038 (2000).","journal-title":"J Clin Oncol"},{"key":"BFsdata2018304_CR12","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","volume":"35","author":"T Lehrnbecher","year":"2017","unstructured":"Lehrnbecher, T. et al. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. J Clin Oncol 35, 2082\u20132094, https:\/\/doi.org\/10.1200\/JCO.2016.71.7017 (2017).","journal-title":"J Clin Oncol"},{"key":"BFsdata2018304_CR13","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/pbc.26121","volume":"63","author":"M Delebarre","year":"2016","unstructured":"Delebarre, M., Tiphaine, A., Martinot, A. & Dubos, F. Risk-stratification management of febrile neutropenia in pediatric hematology-oncology patients: Results of a French nationwide survey. Pediatric Blood & Cancer 63, 2167\u20132172, https:\/\/doi.org\/10.1002\/pbc.26121 (2016).","journal-title":"Pediatric Blood & Cancer"},{"key":"BFsdata2018304_CR14","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/pbc.25106","volume":"61","author":"M Delebarre","year":"2014","unstructured":"Delebarre, M., Macher, E., Mazingue, F., Martinot, A. & Dubos, F. Which decision rules meet methodological standards in children with febrile neutropenia? Results of a systematic review and analysis. Pediatric Blood & Cancer 61, 1786\u20131791, https:\/\/doi.org\/10.1002\/pbc.25106 (2014).","journal-title":"Pediatric Blood & Cancer"},{"key":"BFsdata2018304_CR15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/pbc.22586","volume":"55","author":"E Macher","year":"2010","unstructured":"Macher, E. et al. Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia. Pediatric Blood & Cancer 55, 662\u2013667, https:\/\/doi.org\/10.1002\/pbc.22586 (2010).","journal-title":"Pediatric Blood & Cancer"},{"key":"BFsdata2018304_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/MOH.0b013e32834da951","volume":"19","author":"F Dubos","year":"2012","unstructured":"Dubos, F., Delebarre, M. & Martinot, A. Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia. Current opinion in hematology 19, 39\u201343, https:\/\/doi.org\/10.1097\/MOH.0b013e32834da951 (2012).","journal-title":"Current opinion in hematology"},{"key":"BFsdata2018304_CR17","doi-asserted-by":"publisher","first-page":"e26935","DOI":"10.1002\/pbc.26935","volume":"65","author":"RP Ojha","year":"2018","unstructured":"Ojha, R. P., Asdahl, P. H., Steyerberg, E. W. & Schroeder, H. Predicting bacterial infections among pediatric cancer patients with febrile neutropenia: External validation of the PICNICC model. Pediatric Blood & Cancer 65, e26935, https:\/\/doi.org\/10.1002\/pbc.26935 (2018).","journal-title":"Pediatric Blood & Cancer"},{"key":"BFsdata2018304_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/INF.0000000000001777","volume":"37","author":"GM Haeusler","year":"2018","unstructured":"Haeusler, G. M. et al. External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules. Pediatr Infect Dis J 37, 329\u2013335, https:\/\/doi.org\/10.1097\/INF.0000000000001777 (2018).","journal-title":"Pediatr Infect Dis J"},{"key":"BFsdata2018304_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/pbc.21205","volume":"49","author":"C Hartel","year":"2007","unstructured":"Hartel, C., Deuster, M., Lehrnbecher, T. & Schultz, C. Current approaches for risk stratification of infectious complications in pediatric oncology. Pediatr Blood Cancer 49, 767\u2013773, https:\/\/doi.org\/10.1002\/pbc.21205 (2007).","journal-title":"Pediatr Blood Cancer"},{"key":"BFsdata2018304_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pbc.25335","volume":"62","author":"GM Haeusler","year":"2015","unstructured":"Haeusler, G. M. et al. Core outcomes and definitions for pediatric fever and neutropenia research: a consensus statement from an international panel. Pediatr Blood Cancer 62, 483\u2013489, https:\/\/doi.org\/10.1002\/pbc.25335 (2015).","journal-title":"Pediatr Blood Cancer"},{"key":"BFsdata2018304_CR21","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1038\/bjc.2016.137","volume":"114","author":"RS Phillips","year":"2016","unstructured":"Phillips, R. S. et al. Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis. Br J Cancer 114, e17, https:\/\/doi.org\/10.1038\/bjc.2016.137 (2016).","journal-title":"Br J Cancer"},{"key":"BFsdata2018304_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejca.2016.05.027","volume":"64","author":"RS Phillips","year":"2016","unstructured":"Phillips, R. S. et al. Risk stratification in febrile neutropenic episodes in adolescent\/young adult patients with cancer. Eur J Cancer 64, 101\u2013106, https:\/\/doi.org\/10.1016\/j.ejca.2016.05.027 (2016).","journal-title":"Eur J Cancer"},{"key":"BFsdata2018304_CR23","doi-asserted-by":"publisher","first-page":"180038","DOI":"10.1038\/sdata.2018.38","volume":"5","author":"AN von Allmen","year":"2018","unstructured":"von Allmen, A. N., Zermatten, M. G., Leibundgut, K., Agyeman, P. & Ammann, R. A. Pediatric patients at risk for fever in chemotherapy-induced neutropenia in Bern, Switzerland, 1993\u20132012. Scientific Data 5, 180038, https:\/\/doi.org\/10.1038\/sdata.2018.38 (2018).","journal-title":"Scientific Data"},{"key":"BFsdata2018304_CR24","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/pbc.21726","volume":"51","author":"S Wicki","year":"2008","unstructured":"Wicki, S. et al. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy? Pediatr Blood Cancer 51, 778\u2013783, https:\/\/doi.org\/10.1002\/pbc.21726 (2008).","journal-title":"Pediatr Blood Cancer"},{"key":"BFsdata2018304_CR25","doi-asserted-by":"publisher","unstructured":"von Allmen, A. N., Zermatten, M. G. & Ammann, R. A. Project 17B: Bern FN Core: Pediatric patients at risk for fever in chemotherapy-induced neutropenia (FN) in Bern, Switzerland, 1993\u20132012 Figsharehttps:\/\/doi.org\/10.6084\/m9.figshare.4765216.v5 (2018).","DOI":"10.6084\/m9.figshare.4765216.v5"},{"key":"BFsdata2018304_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/pbc.21129","volume":"50","author":"G Michel","year":"2008","unstructured":"Michel, G. et al. Incidence of childhood cancer in Switzerland: The Swiss Childhood Cancer Registry. Pediatric Blood & Cancer 50, 46\u201351, https:\/\/doi.org\/10.1002\/pbc.21129 (2008).","journal-title":"Pediatric Blood & Cancer"},{"key":"BFsdata2018304_CR27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/pbc.24380","volume":"60","author":"P Binz","year":"2013","unstructured":"Binz, P. et al. Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: a retrospective two-center cohort study. Pediatr Blood Cancer 60, 799\u2013805, https:\/\/doi.org\/10.1002\/pbc.24380 (2013).","journal-title":"Pediatr Blood Cancer"},{"key":"BFsdata2018304_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/pbc.21097","volume":"49","author":"LJ Schlapbach","year":"2007","unstructured":"Schlapbach, L. J. et al. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients. Pediatr Blood Cancer 49, 11\u201316, https:\/\/doi.org\/10.1002\/pbc.21097 (2007).","journal-title":"Pediatr Blood Cancer"},{"key":"BFsdata2018304_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.PCC.0000185476.35550.B2","volume":"7","author":"MM Nimah","year":"2006","unstructured":"Nimah, M. M., Bshesh, K., Callahan, J. D. & Jacobs, B. R. Infrared tympanic thermometry in comparison with other temperature measurement techniques in febrile children. Pediatr Crit Care Med 7, 48\u201355 (2006).","journal-title":"Pediatr Crit Care Med"},{"key":"BFsdata2018304_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00005792-198205000-00003","volume":"61","author":"PA Pizzo","year":"1982","unstructured":"Pizzo, P. A., Robichaud, K. J., Wesley, R. & Commers, J. R. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine (Baltimore) 61, 153\u2013165 (1982).","journal-title":"Medicine (Baltimore)"},{"key":"BFsdata2018304_CR31","doi-asserted-by":"publisher","first-page":"e0117528","DOI":"10.1371\/journal.pone.0117528","volume":"10","author":"RA Ammann","year":"2015","unstructured":"Ammann, R. A., Teuffel, O., Agyeman, P., Amport, N. & Leibundgut, K. The influence of different fever definitions on the rate of fever in neutropenia diagnosed in children with cancer. PLoS One 10, e0117528, https:\/\/doi.org\/10.1371\/journal.pone.0117528 (2015).","journal-title":"PLoS One"},{"key":"BFsdata2018304_CR32","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/00006454-199704000-00003","volume":"16","author":"R Charnas","year":"1997","unstructured":"Charnas, R., Luthi, A. R. & Ruch, W. Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Children. Pediatr Infect Dis J 16, 346\u2013353 (1997).","journal-title":"Pediatr Infect Dis J"},{"key":"BFsdata2018304_CR33","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1097\/INF.0b013e318215a290","volume":"30","author":"P Agyeman","year":"2011","unstructured":"Agyeman, P. et al. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study. Pediatr Infect Dis J 30, e114\u2013e119, https:\/\/doi.org\/10.1097\/INF.0b013e318215a290 (2011).","journal-title":"Pediatr Infect Dis J"},{"key":"BFsdata2018304_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/pbc.23277","volume":"59","author":"F L\u00fcthi","year":"2012","unstructured":"L\u00fcthi, F. et al. Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: Results of the prospective multicenter SPOG 2003 FN study. Pediatr Blood Cancer 59, 90\u201395 (2012).","journal-title":"Pediatr Blood Cancer"},{"key":"BFsdata2018304_CR35","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/pbc.24662","volume":"60","author":"GM Haeusler","year":"2013","unstructured":"Haeusler, G. M., Phillips, R. S., Lehrnbecher, T., Sung, L. & Ammann, R. A. The reporting of outcomes in studies of fever and neutropenia in children with cancer: Time for consensus. Pediatric Blood & Cancer 60, 1563\u20131564, https:\/\/doi.org\/10.1002\/pbc.24662 (2013).","journal-title":"Pediatric Blood & Cancer"},{"key":"BFsdata2018304_CR36","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1056\/NEJM199907293410502","volume":"341","author":"WV Kern","year":"1999","unstructured":"Kern, W. V. et al. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 341, 312\u2013318, https:\/\/doi.org\/10.1056\/NEJM199907293410502 (1999).","journal-title":"N Engl J Med"},{"key":"BFsdata2018304_CR37","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.5769732","author":"M. G. Zermatten","year":"2018","unstructured":"Zermatten, M. G., Koenig, C., von Allmen, A., & Ammann, R. A. Figshare https:\/\/doi.org\/10.6084\/m9.figshare.5769732 (2018)"}],"container-title":["Scientific Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/sdata2018304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/sdata2018304","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sdata2018304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/sdata2018304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:03:46Z","timestamp":1671253426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sdata2018304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3,12]]}},"alternative-id":["BFsdata2018304"],"URL":"https:\/\/doi.org\/10.1038\/sdata.2018.304","relation":{"references":[{"id-type":"doi","id":"http:\/\/doi.org\/10.6084\/m9.figshare.5769732","asserted-by":"subject"}]},"ISSN":["2052-4463"],"issn-type":[{"type":"electronic","value":"2052-4463"}],"subject":[],"published":{"date-parts":[[2019,1,15]]},"assertion":[{"value":"7 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180304"}}